TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization

Part of paid clinical trials in Cincinnati, Ohio.

Sponsor
T. John Winhusen, PhD
Study ID
NCT07780097
Status
Recruiting
Apply to this trial

Conditions

  • Opioid Use Disorder
  • Opioid Use Disorder, Moderate
  • Opioid Use Disorder, Severe

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TRTME — BEHAVIORAL
    The TRTME intervention includes three elements that have all been previously studied by our research team: 1) brief, personally-tailored education to correct inaccurate, common misconceptions about MOUD and to address knowledge gaps about opioid-overdose; 2) with personally-tailored feedback on the individual's risk factors for experiencing an opioid-overdose; and 3) review of MOUD testimonial videos.

Study Details

The primary objective of this study is to evaluate the ability of TRTME to increase initiation of MOUD outpatient treatment and MOUD knowledge in hospitalized patients with OUD deemed to be good candidates for MOUD by the UCMC Addiction Consult Team (ACT). The secondary objective is to evaluate the ability of TRTME to decrease stigma and increase drug self-efficacy.

Key Dates

First listed
Aug 21, 2026
Start date
Aug 12, 2026
Status verified
Aug 2026
Primary completion
Feb 28, 2027
Completion
Feb 28, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • No Intervention: Control
    Control participants will be offered two SAMHSA handouts: 1) "Opioid Overdose Prevention Toolkit: Safety Advice for Patients and Family Members"; and 2) "Medication-Assisted Treatment for Opioid Addiction: Facts for Families and Friends". These handouts can be offered as physical copies or electronically.
  • Experimental: TRTME
    TRTME participants will be offered a 15-minute intervention in which a trained research staff member reviews personal feedback reports with the recipient to provide information on: 1) the items missed on the knowledge assessment; and 2) their personal overdose risk factors. TRTME participants will also have the opportunity to view short videos from patients talking about their experiences with methadone or buprenorphine treatment.

Primary Outcome Measure

Outpatient MOUD initiation [ Time Frame: 30 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Cincinnati Addiction Sciences DivisionCincinnatiOhio45229-

Find similar trials in Cincinnati, OH

By research site
University of Cincinnati Addiction Sciences Division· Cincinnati, OH

Related Studies